US 10029017
Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug
granted A61KA61K38/06A61K47/60
Quick answer
US patent 10029017 (Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug) held by The Regents of the University of California expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/06, A61K47/60, A61K47/64, A61K47/645